AngioDynamics (ANGO) insider buying

Healthcare · Medical Instruments & Supplies · Market cap $473M

3 open-market purchases of ANGO by AngioDynamics's executives and directors since October 2025, worth $239,532 in total, from SEC Form 4 filings.

The most recent: Lawrence T Weiss bought $118,100 on October 21, 2025.

The biggest buyer over the period is Lawrence T Weiss: 1 purchase, $118,100.

By year

YearPurchasesValue
20253$239,532

Biggest buyers

InsiderBuysValue
Lawrence T Weiss
1$118,100
James C Clemmer
1$111,500
Stephen A Trowbridge
1$9,932

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Oct 21, 2025 Lawrence T Weiss
 10,000$11.81$118,100 Form 4
Oct 13, 2025 Stephen A Trowbridge
 890$11.16$9,932 Form 4
Oct 9, 2025 James C Clemmer
 10,000$11.15$111,500 Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ANGO.
Open ANGO in Investingly

Questions

Are AngioDynamics insiders buying the stock?

3 open-market purchases of ANGO by AngioDynamics's executives and directors since October 2025, worth $239,532 in total, from SEC Form 4 filings. The most recent: Lawrence T Weiss bought $118,100 on October 21, 2025.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From AngioDynamics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.